This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (17)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Macular Disorders  • Alert me on articles by topic

Annie Chan, BS; Jay S. Duker, MD

Arch Ophthalmol. 2005;123:939-943.

Objective  To describe a standardized method for reporting quantitative changes in macular thickening using optical coherence tomography (OCT).

Methods  The proposed method consists of calculating the actual change in central foveal thickening (the initial pretreatment thickness minus the posttreatment thickness) using OCT and dividing that value by the potential change (the initial pretreatment thickness minus the normal thickness based on normative data) to provide the total improvement in macular edema as a percentage. We refer to this method as the standardized change in macular thickening (SCMT). To illustrate the effectiveness of this method, we performed a retrospective review of 2 studies that evaluated different strategies for treating refractory macular edema.

Results  Patients treated with intravitreal triamcinolone acetonide for refractory diabetic macular edema had an overall SCMT of approximately 75%, 78%, and 55% at the 1-, 3-, and 6-month follow-up visits, respectively. More than half of the patients in the study cohort (9 of 16 patients) experienced greater than 80% SCMT at the last follow-up visit. Patients who underwent vitrectomy for a taut, thickened posterior hyaloid on OCT responded with an SCMT of approximately 78% at the 3-month follow-up visit and 87% at the final follow-up visit (mean, 19 months). Patients who underwent vitrectomy for diabetic macular edema unresponsive to laser photocoagulation but with no evidence of vitreomacular traction experienced an SCMT of 37% at the 3-month follow-up visit and 20% at the final follow-up visit (mean, 17 months).

Conclusion  The proposed method offers an objective and intuitive basis for evaluating and comparing the efficacy of different therapeutic modalities.

Author Affiliations: New England Eye Center, Tufts-New England Medical Center, Tufts University School of Medicine, Boston, Mass.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A prospective randomised trial of different doses of intravitreal triamcinolone for diabetic macular oedema
Lam et al.
Br. J. Ophthalmol. 2007;91:199-203.
ABSTRACT | FULL TEXT  

Optical Coherence Tomography in Group 2A Idiopathic Juxtafoveolar Retinal Telangiectasis
Gaudric et al.
Arch Ophthalmol 2006;124:1410-1419.
ABSTRACT | FULL TEXT  

Diabetic Macular Edema: Correlation between Microperimetry and Optical Coherence Tomography Findings.
Vujosevic et al.
IOVS 2006;47:3044-3051.
ABSTRACT | FULL TEXT  

Distribution of macular thickness by optical coherence tomography: findings from a population-based study of 6-year-old children.
Huynh et al.
IOVS 2006;47:2351-2357.
ABSTRACT | FULL TEXT